Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Biogen Idec opts in to commercialization agreement for anti-TNF biosimilars in Europe

Dec. 23, 2013

Potent ROR-gamma inverse agonist demonstrates efficacy in a murine model of arthritis

Dec. 20, 2013

Novel antibodies for autoimmune disorders disclosed by German scientists

Dec. 19, 2013

Novel BTK inhibitors patented by Pharmascience

Dec. 18, 2013

Asahi Kasei Pharma presents promising phase I results for AK-106-001616

Dec. 17, 2013

Covagen secures series B financing to advance COVA-322

Dec. 12, 2013

Glenmark Pharmaceuticals discloses novel ROR-gamma modulators

Dec. 5, 2013

Incyte Corp. presents new JAK1 inhibitors

Dec. 5, 2013

New CTLA-4 variants selected by MedImmune

Dec. 4, 2013

Novel immunogenic peptide compositions presented by French group

Dec. 3, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...